Literature DB >> 7191258

[On the bioavailability of hydrochlorothiazide and triamterene from commercial drugs (author's transl)].

H Knauf, W Möhrke, E Mutschler, K D Völger.   

Abstract

In a study on the bioavailability of triamterene and hydrochlorothiazide from 3 diuretics, preparation A (25 mg hydrochlorothiazide), preparation B (50 mg triamterene) and preparation C (combination of hydrochlorothiazide and triamterene), the data for tmax, Cmax, AUC and the cumulative urine excretion were determined in 7 healthy volunteers. The different formulations of the diuretics influenced the kinetics of the agents. The in vivo data agreed well with those obtained in vitro. Plasma levels of triamterene and its active metabolite from preparation C were reached more rapidly than from preparation B. However, the bioavailability of the agents was not significant different in the two diuretics when given immediately after breakfast. The AUC-data of hydrochlorothiazide determined after administration of preparation A or C do not differ significantly, only the comulative excretion of hydrochlorothiazide in urine is greater after application of preparation A than after application of preparation C.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7191258

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  3 in total

1.  Pharmacokinetics of triamterene and its metabolite in man.

Authors:  J Hasegawa; E T Lin; R L Williams; F Sörgel; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1982-10

2.  Pharmacokinetics of triamterene after i.v. administration to man: determination of bioavailability.

Authors:  H J Gilfrich; G Kremer; W Möhrke; E Mutschler; K D Völger
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 3.  Metabolites of antihypertensive drugs. An updated review of their clinical pharmacokinetic and therapeutic implications.

Authors:  A Ebihara; A Fujimura
Journal:  Clin Pharmacokinet       Date:  1991-11       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.